Kornelia Polyak has been elected to the 2024 class of the American Academy of Arts and Sciences – Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn:
“Kornelia Polyak, co-leader of the Dana-Farber Harvard Cancer Center Cell Biology Program and professor of medicine at Harvard Medical School, has been elected to the 2024 class of the American Academy of Arts and Sciences and Sciences (AAAS). Polyak is one of 250 recently elected members who are being recognized for excellence and invited to uphold the AAAS’s mission of engaging across disciplines. Induction ceremonies for new members will be held this September in Cambridge, Massachusetts.
Polyak has been and continues to be a leading basic and translational investigator in breast cancer research and a pioneer in the study of tumors as ecosystems, emphasizing the importance of the tumor microenvironment in disease progression and therapeutic resistance. Her current research focuses on breast tumor evolution through the analysis of patient tissue samples and preclinical models. Polyak is also actively studying the role of risk factors, such as age, genetic predisposition, and diet, in cancer initiation and progression with the goal of designing novel approaches to prevent cancer.
Founded in 1780 by John Adams, John Hancock, and others, the AAAS is an independent research center that convenes leaders from across disciplines, professions, and perspectives to address important national and world issues. Members, of which more than 14,500 have been elected since the AAAS was established, include those who discover and advance knowledge and apply it to solve the problems of society.”